Citations (84)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Madia Lozupone, Giuseppe Berardino, Anita Mollica, Rodolfo Sardone, Vittorio Dibello, Roberta Zupo, Luisa Lampignano, Fabio Castellana, Ilaria Bortone, Roberta Stallone, Antonio Daniele, Mario Altamura, Antonello Bellomo, Vincenzo Solfrizzi & Francesco Panza. (2022) ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer’s disease. Expert Opinion on Investigational Drugs 31:8, pages 759-771.
Read now
Read now
Bruno P. Imbimbo & Mark Watling. (2021) What have we learned from past failures of investigational drugs for Alzheimer’s disease?. Expert Opinion on Investigational Drugs 30:12, pages 1175-1182.
Read now
Read now
Bruno P. Imbimbo, Stefania Ippati, Mark Watling & Claudia Balducci. (2021) Accelerating Alzheimer’s disease drug discovery and development: what’s the way forward?. Expert Opinion on Drug Discovery 16:7, pages 727-735.
Read now
Read now
Shipeng Li, Hexiang Zhao, Jinghui Li, Jiajia Hao & Hualin Yu. (2021) A series of molecular modeling techniques to reveal selective mechanisms of inhibitors to β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) and β-site amyloid precursor protein cleaving enzyme 2 (BACE2). Journal of Biomolecular Structure and Dynamics 39:8, pages 2824-2837.
Read now
Read now
Bruno P. Imbimbo, Madia Lozupone, Mark Watling & Francesco Panza. (2020) Discontinued disease-modifying therapies for Alzheimer’s disease: status and future perspectives. Expert Opinion on Investigational Drugs 29:9, pages 919-933.
Read now
Read now
Madia Lozupone, Vincenzo Solfrizzi, Francesca D’Urso, Ilaria Di Gioia, Rodolfo Sardone, Vittorio Dibello, Roberta Stallone, Angelo Liguori, Chiara Ciritella, Antonio Daniele, Antonello Bellomo, Davide Seripa & Francesco Panza. (2020) Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs. Expert Opinion on Emerging Drugs 25:3, pages 319-335.
Read now
Read now
Articles from other publishers (78)
Ruchita Gharat, Gargi Dixit, Mihir Khambete & Arati Prabhu. (2024) Targets, trials and tribulations in Alzheimer therapeutics. European Journal of Pharmacology 962, pages 176230.
Crossref
Crossref
Paula Zaręba, Kamil Łątka, Gabriela Mazur, Beata Gryzło, Anna Pasieka, Justyna Godyń, Dawid Panek, Anna Skrzypczak-Wiercioch, Georg C. Höfner, Gniewomir Latacz, Maciej Maj, Alba Espargaró, Raimon Sabaté, Krzysztof Jóźwiak, Klaus T. Wanner, Kinga Sałat, Barbara Malawska, Katarzyna Kulig & Marek Bajda. (2023) Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease. European Journal of Medicinal Chemistry 261, pages 115832.
Crossref
Crossref
Qiqi Chen, Jingying Wang, Yuhang Gao, Zixin Wang, Xiujun Gao & Peisheng Yan. (2023) Biotransformation of American Ginseng Stems and Leaves by an Endophytic Fungus Umbelopsis sp. and Its Effect on Alzheimer’s Disease Control. Nutrients 15:23, pages 4878.
Crossref
Crossref
Ting-Yuan Zhou, Rui-Xia Ma, Jia Li, Bin Zou, Hui Yang, Rui-Yin Ma, Zi-Qi Wu, Juan Li & Yao Yao. (2023) Review of PINK1-Parkin-mediated mitochondrial autophagy in Alzheimer's disease. European Journal of Pharmacology 959, pages 176057.
Crossref
Crossref
Ayesha Khan, Richard Killick, Daniel Wirth, Dominique Hoogland, Kalina Hristova, Jakob P. Ulmschneider, Christopher R. King & Martin B. Ulmschneider. (2023) Masking the transmembrane region of the amyloid β precursor protein as a safe means to lower amyloid β production. Alzheimer's & Dementia: Translational Research & Clinical Interventions 9:4.
Crossref
Crossref
Sankar P. Gorthi & Dulari Gupta. (2023) Alzheimer’s Disease: Treatment Today and Tomorrow. Annals of Indian Academy of Neurology.
Crossref
Crossref
Tian Liu, Kai Su, Weiye Cai, Hui Ao & Mingxiu Li. (2023) Therapeutic potential of puerarin against cerebral diseases: From bench to bedside. European Journal of Pharmacology 953, pages 175695.
Crossref
Crossref
Mengyao Shan, Yunfan Bai, Xiaoxue Fang, Xintian Lan, Yegang Zhang, Yiming Cao, Difu Zhu & Haoming Luo. (2023) American Ginseng for the Treatment of Alzheimer’s Disease: A Review. Molecules 28:15, pages 5716.
Crossref
Crossref
JiMin Kim, Hanna Jeon, Hye Yun Kim & YoungSoo Kim. (2023) Failure, Success, and Future Direction of Alzheimer Drugs Targeting Amyloid‐β Cascade: Pros and Cons of Chemical and Biological Modalities. ChemBioChem.
Crossref
Crossref
Liping Huang, Xiaoqin Zhong, Yuanhang Xu, Minzhen Deng & Zhongliu Zhou. (2023) β-asarone Protects p-tau from Okadaic Acid in PC12 Cells by Activating PP2A and Involving Akt/mTOR/Beclin-1 Pathway. Pharmacognosy Magazine.
Crossref
Crossref
Like Lin, Cong Li, Tingting Li, Jingyi Zheng, Yu Shu, Jingjing Zhang, Yehua Shen & Difeng Ren. (2023) Plant‐derived peptides for the improvement of Alzheimer's disease: Production, functions, and mechanisms. Food Frontiers 4:2, pages 677-699.
Crossref
Crossref
Yue Liu, Guifeng Zhou, Li Song, Qixin Wen, Shiqi Xie, Long Chen, Lu Wang, Xiaoyong Xie, Xue Chen, Yalan Pu & Guojun Chen. (2023) DEAD-Box Helicase 17 Promotes Amyloidogenesis by Regulating BACE1 Translation. Brain Sciences 13:5, pages 745.
Crossref
Crossref
Masuo Ohno. (2023) Accelerated long-term forgetting: A sensitive paradigm for detecting subtle cognitive impairment and evaluating BACE1 inhibitor efficacy in preclinical Alzheimer's disease. Frontiers in Dementia 2.
Crossref
Crossref
Paulo Cézar Prado, Josélia Alencar Lima, Lidilhone Hamerski & Magdalena Nascimento Rennó. (2023) Natural Products with BACE1 and GSK3β Inhibitory Activity. Mini-Reviews in Medicinal Chemistry 23:7, pages 881-895.
Crossref
Crossref
Bachir Latli, Matt J. Hrapchak, Jonathan T. Reeves, Heewon Lee & Jinhua J. Song. (2023)
Synthesis of beta‐site amyloid precursor protein‐cleaving enzyme 1 inhibitors
BI 1147560
and
BI 1181181
labeled with carbon‐14 and deuterium
. Journal of Labelled Compounds and Radiopharmaceuticals 66:4-6, pages 145-154.
Crossref
Crossref
David A. Loeffler. (2023) Experimental approaches for altering the expression of Abeta‐degrading enzymes. Journal of Neurochemistry 164:6, pages 725-763.
Crossref
Crossref
Bhawana Sati, Tyagi Alka & Anurag Chaudhary. (2023) Structural Scaffolds as Anti- Alzheimer Agents. Medicinal Chemistry 19:2, pages 132-146.
Crossref
Crossref
Jinfei Mei, Wen Xu, Wenqi Gao, Chuanbo Wang, Yvning Guan, Sajjad Ahmad & Hongqi Ai. (2023) Identification and characterization of the conformation and size of amyloid-β (42) oligomers targeting the receptor LilrB2. Physical Chemistry Chemical Physics.
Crossref
Crossref
Bruno P. Imbimbo, Stefania Ippati, Mark Watling & Camillo Imbimbo. (2023) Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies. Pharmacological Research 187, pages 106631.
Crossref
Crossref
Swati Mishra, Coen Van Deursen, Aiko Robert, Rik Van Der Kant & Jessica E. Young. 2023. Phenotyping of Human iPSC-derived Neurons. Phenotyping of Human iPSC-derived Neurons
243
261
.
Saroj Verma & Debashish Paramanick. 2023. Deciphering Drug Targets for Alzheimer’s Disease. Deciphering Drug Targets for Alzheimer’s Disease
95
109
.
Esteban M. Lucero, Ronald K. Freund, Alexandra Smith, Noah R. Johnson, Breanna Dooling, Emily Sullivan, Olga Prikhodko, Md. Mahiuddin Ahmed, David A. Bennett, Timothy J. Hohman, Mark L. Dell’Acqua, Heidi J. Chial & Huntington Potter. (2022) Increased KIF11/kinesin-5 expression offsets Alzheimer Aβ-mediated toxicity and cognitive dysfunction. iScience 25:11, pages 105288.
Crossref
Crossref
Muhammad Aamir Javed, Saba Bibi, Muhammad Saeed Jan, Muhammad Ikram, Asma Zaidi, Umar Farooq, Abdul Sadiq & Umer Rashid. (2022) Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer's disease: synthesis, pharmacology, toxicity and docking studies. RSC Advances 12:35, pages 22503-22517.
Crossref
Crossref
Neeraj Singh, Brati Das, John ZhouXiangyou HuRiqiang Yan. (2022) Targeted BACE-1 inhibition in microglia enhances amyloid clearance and improved cognitive performance. Science Advances 8:29.
Crossref
Crossref
Xia Zhao, Li Xiong, Lingyu She, Liwei Li, Ping Huang & Guang Liang. (2022) The role and therapeutic implication of protein tyrosine phosphatases in Alzheimer’s disease. Biomedicine & Pharmacotherapy 151, pages 113188.
Crossref
Crossref
Neeraj Singh, Marc R. Benoit, John ZhouBrati Das, Jose Davila-Velderrain, Manolis Kellis, Li-Huei Tsai, Xiangyou HuRiqiang Yan. (2022) BACE-1 inhibition facilitates the transition from homeostatic microglia to DAM-1. Science Advances 8:24.
Crossref
Crossref
Teresa Pardo-Moreno, Anabel González-Acedo, Antonio Rivas-Domínguez, Victoria García-Morales, Francisco Jose García-Cozar, Juan Jose Ramos-Rodríguez & Lucía Melguizo-Rodríguez. (2022) Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives. Pharmaceutics 14:6, pages 1117.
Crossref
Crossref
Jana Klose, Carola Griehl, Steffen Roßner & Stephan Schilling. (2022) Natural Products from Plants and Algae for Treatment of Alzheimer’s Disease: A Review. Biomolecules 12:5, pages 694.
Crossref
Crossref
Satyakam Bhagavati. (2022) Commentary: Diagnostic Accuracy of Blood-Based Biomarker Panels: A Systematic Review. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Mariana G. Fronza, Manoela Sacramento, Diego Alves, Domenico Praticò & Lucielli Savegnago. (2022) 1-(7-Chloroquinolin-4-yl)-N-(4-Methoxybenzyl)-5-Methyl-1H-1,2, 3-Triazole-4- carboxamide Reduces Aβ Formation and Tau Phosphorylation in Cellular Models of Alzheimer’s Disease. Neurochemical Research 47:4, pages 1110-1122.
Crossref
Crossref
Semira Abdi Beshir, A. M. Aadithsoorya, Affana Parveen, Sheron Sir Loon Goh, Nadia Hussain & Vineetha Bharathan Menon. (2022) Aducanumab Therapy to Treat Alzheimer’s Disease: A Narrative Review. International Journal of Alzheimer's Disease 2022, pages 1-10.
Crossref
Crossref
Lili Pan, Qian He, Yi Wu, Ni Zhang, Huawei Cai, Bo Yang, Yuxi Wang, Yunchun Li & Xiaoai Wu. (2022) Synthesis, radiolabeling, and evaluation of a potent β-site APP cleaving enzyme (BACE1) inhibitor for PET imaging of BACE1 in vivo. Bioorganic & Medicinal Chemistry Letters 59, pages 128543.
Crossref
Crossref
Jin Li, Hongni Yu, Chuan Yang, Tao Ma & Yuan Dai. (2022) Therapeutic Potential and Molecular Mechanisms of Echinacoside in Neurodegenerative Diseases. Frontiers in Pharmacology 13.
Crossref
Crossref
Samuel C. Ugbaja, Isiaka A. Lawal, Hezekiel M. Kumalo & Monsurat M. Lawal. (2022) Alzheimer's Disease and β-secretase Inhibition: An Update with a Focus
on Computer-aided Inhibitor Design. Current Drug Targets 23:3, pages 266-285.
Crossref
Crossref
Brian A. Willis, Stephen L. Lowe, Scott A. Monk, Patrick J. Cocke, Christopher D. Aluise, Leonard N. Boggs, Anthony R. Borders, Richard A. Brier, Robert A. Dean, Steven J. Green, Douglas E. James, Stanford S. Jhee, Qun Lin, Albert C. Lo, Patrick C. May, Brian M. Watson, Leonard L. Winneroski, Zhixiang Yang, Jennifer A. Zimmer, David L. McKinzie & Dustin J. Mergott. (2022) Robust Pharmacodynamic Effect of LY3202626, a Central Nervous System Penetrant, Low Dose BACE1 Inhibitor, in Humans and Nonclinical Species. Journal of Alzheimer's Disease Reports 6:1, pages 1-15.
Crossref
Crossref
Giovanni B. Frisoni, Daniele Altomare, Dietmar Rudolf Thal, Federica Ribaldi, Rik van der Kant, Rik Ossenkoppele, Kaj Blennow, Jeffrey Cummings, Cornelia van Duijn, Peter M. Nilsson, Pierre-Yves Dietrich, Philip Scheltens & Bruno Dubois. (2021) The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nature Reviews Neuroscience 23:1, pages 53-66.
Crossref
Crossref
Adrian L. Oblak, Zackary A. Cope, Sara K. Quinney, Ravi S. Pandey, Carla Biesdorf, Andi R. Masters, Kristen D. Onos, Leslie Haynes, Kelly J. Keezer, Jill A. Meyer, Jonathan S. Peters, Scott A. Persohn, Amanda A. Bedwell, Kierra Eldridge, Rachael Speedy, Gabriela Little, Sean‐Paul Williams, Brenda Noarbe, Andre Obenaus, Michael Sasner, Gareth R. Howell, Gregory W. Carter, Harriet Williams, Bruce T. Lamb, Paul R. Territo & Stacey J. Sukoff Rizzo. (2022) Prophylactic evaluation of verubecestat on disease‐ and symptom‐modifying effects in 5XFAD mice. Alzheimer's & Dementia: Translational Research & Clinical Interventions 8:1.
Crossref
Crossref
Thomas Gabriel Schreiner & Bogdan Ovidiu Popescu. (2021) Amyloid Beta Dynamics in Biological Fluids—Therapeutic Impact. Journal of Clinical Medicine 10:24, pages 5986.
Crossref
Crossref
Victoria García-Morales, Anabel González-Acedo, Lucía Melguizo-Rodríguez, Teresa Pardo-Moreno, Víctor Javier Costela-Ruiz, María Montiel-Troya & Juan José Ramos-Rodríguez. (2021) Current Understanding of the Physiopathology, Diagnosis and Therapeutic Approach to Alzheimer’s Disease. Biomedicines 9:12, pages 1910.
Crossref
Crossref
Danko Jeremic, Lydia Jiménez-Díaz & Juan D. Navarro-López. (2021) Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review. Ageing Research Reviews 72, pages 101496.
Crossref
Crossref
A. A. Smirnova, L. N. Prakhova & A. G. Ilves. (2021) Immunopathogenesis and immunotherapeutic approaches of neurodegenerative and cerebrovascular diseases with cognitive impairment. The current state of the problem and prospects. Russian neurological journal 26:5, pages 4-15.
Crossref
Crossref
Rainer Machauer, Rainer Lueoend, Konstanze Hurth, Siem J. Veenstra, Heinrich Rueeger, Markus Voegtle, Marina Tintelnot-Blomley, Jean-Michel Rondeau, Laura H. Jacobson, Grit Laue, Karen Beltz & Ulf Neumann. (2021) Discovery of Umibecestat (CNP520): A Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor for the Prevention of Alzheimer’s Disease. Journal of Medicinal Chemistry 64:20, pages 15262-15279.
Crossref
Crossref
Girdhari Lal Gupta & Nikita Patil Samant. (2021) Current druggable targets for therapeutic control of Alzheimer's disease. Contemporary Clinical Trials 109, pages 106549.
Crossref
Crossref
Yinyi Xiong & Chae-Seok Lim. (2021) Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease. Brain Sciences 11:9, pages 1211.
Crossref
Crossref
Emily Bomasang-Layno & Rachel Bronsther. (2021) Diagnosis and Treatment of Alzheimer’s Disease:. Delaware Journal of Public Health 7:4, pages 74-85.
Crossref
Crossref
Boris Decourt, Fadel Boumelhem, Evans D. PopeIIIIII, Jiong Shi, Zoltan Mari & Marwan Noel Sabbagh. (2021) Critical Appraisal of Amyloid Lowering Agents in AD. Current Neurology and Neuroscience Reports 21:8.
Crossref
Crossref
M. Ouknin, A. Aghraz, M. Chibane, A. Boumezzourh, J. Costa & L. Majidi. (2021) Enzyme inhibitory, antioxidant activity and phytochemical analysis of essential oil from cultivated Rosmarinus officinalis. Journal of Food Measurement and Characterization 15:4, pages 3782-3790.
Crossref
Crossref
Tien-Wei Yu, Hsien-Yuan Lane & Chieh-Hsin Lin. (2021) Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review. International Journal of Molecular Sciences 22:15, pages 8208.
Crossref
Crossref
Jonathan Janssens, Bart Hermans, Marc Vandermeeren, Erio Barale-Thomas, Marianne Borgers, Roland Willems, Greet Meulders, Cindy Wintmolders, Dries Van den Bulck, Astrid Bottelbergs, Luc Ver Donck, Peter Larsen, Dieder Moechars, Wilson Edwards, Marc Mercken & Bianca Van Broeck. (2021) Passive immunotherapy with a novel antibody against 3pE-modified Aβ demonstrates potential for enhanced efficacy and favorable safety in combination with BACE inhibitor treatment in plaque-depositing mice. Neurobiology of Disease 154, pages 105365.
Crossref
Crossref
Kejing Lao, Ruisan Zhang, Yuxuan Dai, Jing Luan, Na Guo, Xi Xu, Yuelin Zhang & Xingchun Gou. (2021) Identification of novel Aβ-LilrB2 inhibitors as potential therapeutic agents for Alzheimer's disease. Molecular and Cellular Neuroscience 114, pages 103630.
Crossref
Crossref
Ruta Dekeryte, Zara Franklin, Claire Hull, Lorenzo Croce, Sarah Kamli-Salino, Oliver Helk, Philip A. Hoffmann, Zhixiang Yang, Gernot Riedel, Mirela Delibegovic & Bettina Platt. (2021) The BACE1 inhibitor LY2886721 improves diabetic phenotypes of BACE1 knock-in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1867:7, pages 166149.
Crossref
Crossref
Daniel K Burns, Robert C Alexander, Kathleen A Welsh-Bohmer, Meredith Culp, Carl Chiang, Janet O’Neil, Rebecca M Evans, Patrick Harrigan, Brenda L Plassman, James R Burke, Jingtao Wu, Michael W Lutz, Stephen Haneline, Adam J Schwarz, Lon S Schneider, Kristine Yaffe, Ann M Saunders, Emiliangelo Ratti, Dag Aarsland, Oda Ackermann, Joscelyn Agron-Figueroa, Thomas Arnold, Peter Bailey, Clive Ballard, Scott Barton, Christine Belden, James Bergthold, Wendy Bond, Ronald Bradley, Walter Braude, Mark Brody, Richard Brown, James Burke, Joseph Butchart, Theresa Campbell, Sandra Carusa, Roger Clarnette, Robert Cohen, Peter Connelly, Jacquelynn Copeland, Elizabeth Coulthard, Jill Crusey, Craig Curtis, Virginia De Sanctis, George Demakis, Natalie Denburg, Mardik Donikyan, Rachelle Doody, Aaron Ellenbogen, Debra Fleischman, Agnes Floel, Concetta Forchetti, Nestor Galvez-Jimenez, Jerome Goldstein, Felicia Goldstein, Kathryn Goozee, Daniel Gruener, Jerry Halsten, Howard Hassman, Elliot Henderson, Heinz-Peter Herbst, Steve Higham, Ronald Hofner, DeRen Huang, Fraser Inglis, Clark Johnson, Joseph Kass, Gregory Kirk, Arne Klostermann, Alex Knopman, Anne Koplin, David Krefetz, Reto Kressig, Rosalyn Lai, Gigi Lefebvre, Gabriel Leger, Mark Leibowitz, Allan Levey, Thomas Leyhe, Scott Losk, Kara Lyons, Jane Martin, Paul Massman, Christopher McWilliam, Silvana Micallef, Lefkos Middleton, Hugh Miller, Jacobo Mintzer, Robert Mitchell, Ricky Mofsen, Andreas Monsch, Philip Moore, Donna Munic-Miller, Marshall Nash, Judith Neugroschl, Margaret Newson, Rupert Noad, Esteban Olivera, Amanda Olley, Omid Omidvar, Mario Parra, Stephen Pearson, Robert Perneczky, Oliver Peters, Guy Potter, Geraint Price, Vanessa Raymont, Linda Rice, Craig Ritchie, Aaron Ritter, Jennifer Robinson, Sylvia Robinson, Jeffrey Ross, Dan Rujescu, Marwan Sabbagh, Ahad Sabet, Laura Samson, John Sass, Manish Saxena, Frederick Schaerf, Eugen Schlegel, Raj Shah, Richard Shingleton, Hamid Sohrabi, Robert Stephenson, Liebhild Stratmann, Pierre Tariot, Stephen Thein, Haydn Till, Nancy Voight, Ralph Votolato, Lorna Wallace, David Watson, Alexander White, Michael Woodward, Edward Zamrini & Christina Zimmerman. (2021) Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet Neurology 20:7, pages 537-547.
Crossref
Crossref
Marie Tautou, Sabiha Eddarkaoui, Florian Descamps, Paul-Emmanuel Larchanché, Jamal El Bakali, Liesel Mary Goveas, Mélanie Dumoulin, Chloé Lamarre, David Blum, Luc Buée, Patricia Melnyk & Nicolas Sergeant. (2021) A ß-Secretase Modulator Decreases Tau Pathology and Preserves Short-Term Memory in a Mouse Model of Neurofibrillary Degeneration. Frontiers in Pharmacology 12.
Crossref
Crossref
David L. McKinzie, Leonard L. Winneroski, Steven J. Green, Erik J. Hembre, Jon A. Erickson, Brian A. Willis, Scott A. Monk, Christopher D. Aluise, Thomas K. Baker, Jose E. Lopez, Jörg Hendle, James P. Beck, Richard A. Brier, Leonard N. Boggs, Anthony R. Borders, Patrick J. Cocke, Pablo Garcia-Losada, Stephen L. Lowe, Brian M. Mathes, Patrick C. May, Warren J. Porter, Stephanie L. Stout, David E. Timm, Brian M. Watson, Zhixiang Yang & Dustin J. Mergott. (2021) Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE Inhibitor. Journal of Medicinal Chemistry 64:12, pages 8076-8100.
Crossref
Crossref
Anna Pasieka, Dawid Panek, Natalia Szałaj, Alba Espargaró, Anna Więckowska, Barbara Malawska, Raimon Sabaté & Marek Bajda. (2021)
Dual Inhibitors of Amyloid-β and Tau Aggregation with Amyloid-β Disaggregating Properties: Extended
In Cellulo
,
In Silico
, and Kinetic Studies of Multifunctional Anti-Alzheimer’s Agents
. ACS Chemical Neuroscience 12:11, pages 2057-2068.
Crossref
Crossref
Wen-Hui Ma, Ai-Fang Chen, Xiao-Yang Xie & Yun-Sheng Huang. (2021) Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease. Neuropharmacology 190, pages 108342.
Crossref
Crossref
Anna Pasieka, Dawid Panek, Jakub Jończyk, Justyna Godyń, Natalia Szałaj, Gniewomir Latacz, Julia Tabor, Eva Mezeiova, Fabien Chantegreil, José Dias, Damijan Knez, Junfeng Lu, Rongbiao Pi, Jan Korabecny, Xavier Brazzolotto, Stanislav Gobec, Georg Höfner, Klaus Wanner, Anna Więckowska & Barbara Malawska. (2021) Discovery of multifunctional anti-Alzheimer’s agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters. European Journal of Medicinal Chemistry 218, pages 113397.
Crossref
Crossref
Masuo Ohno. (2021) Accelerated long‐term forgetting is a BACE1 inhibitor‐reversible incipient cognitive phenotype in Alzheimer’s disease model mice. Neuropsychopharmacology Reports 41:2, pages 255-259.
Crossref
Crossref
Bi‐Rou Zhong, Gui‐Feng Zhou, Li Song, Qi‐Xin Wen, Xiao‐Juan Deng, Yuan‐Lin Ma, Li‐Tian Hu & Guo‐Jun Chen. (2021) TUFM is involved in Alzheimer’s disease‐like pathologies that are associated with ROS. The FASEB Journal 35:5.
Crossref
Crossref
Donald J. AbrahamRichard Young. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
76
.
Jane Barber, Phumzile Sikakana, Claire Sadler, Delphine Baud, Jean-Pierre Valentin & Ruth Roberts. (2021) A target safety assessment of the potential toxicological risks of targeting plasmepsin IX/X for the treatment of malaria. Toxicology Research 10:2, pages 203-213.
Crossref
Crossref
Tingting Pi, Shenjiao Wei, Yongxuan Jiang & Jing-Shan Shi. (2021) High Methionine Diet-Induced Alzheimer’s Disease like Symptoms Are Accompanied by 5-Methylcytosine Elevated Levels in the Brain. Behavioural Neurology 2021, pages 1-16.
Crossref
Crossref
Tauqeerunnisa Syeda & Jason R. Cannon. (2021) Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target. Journal of Biochemical and Molecular Toxicology 35:4.
Crossref
Crossref
Christine Shing Wei Law & Keng Yoon Yeong. (2021) Repurposing Antihypertensive Drugs for the Management of Alzheimer’s Disease. Current Medicinal Chemistry 28:9, pages 1716-1730.
Crossref
Crossref
Reisa Sperling, David Henley, Paul S. Aisen, Rema Raman, Michael C. Donohue, Karin Ernstrom, Michael S. Rafii, Johannes Streffer, Yingqi Shi, Keith Karcher, Nandini Raghavan, Yevgen Tymofyeyev, Jennifer Bogert, H. Robert Brashear, Gerald Novak, John Thipphawong, Ziad S. Saad, Hartmuth Kolb, Hany Rofael, Panna Sanga & Gary Romano. (2021) Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease. JAMA Neurology 78:3, pages 293.
Crossref
Crossref
Kejing Lao, Ruisan Zhang, Jing Luan, Yuelin Zhang & Xingchun Gou. (2021) Therapeutic Strategies Targeting Amyloid-β Receptors and Transporters in Alzheimer’s Disease. Journal of Alzheimer's Disease 79:4, pages 1429-1442.
Crossref
Crossref
KatherineL Marshall & MohamedH Farah. (2021) Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders. Neural Regeneration Research 16:10, pages 1901.
Crossref
Crossref
Allison B. Reiss, Natalie Montufar, Joshua DeLeon, Aaron Pinkhasov, Irving H. Gomolin, Amy D. Glass, Hirra A. Arain & Mark M. Stecker. (2021) Alzheimer Disease Clinical Trials Targeting Amyloid. The Neurologist 26:2, pages 52-61.
Crossref
Crossref
Frédéric Checler, Elissa Afram, Raphaëlle Pardossi-Piquard & Inger Lauritzen. (2021) Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?. Journal of Biological Chemistry 296, pages 100489.
Crossref
Crossref
Gabriel Vargas. 2021. Modern CNS Drug Discovery. Modern CNS Drug Discovery
245
255
.
Tugce Munise Satir, Lotta Agholme, Anna Karlsson, Mattias Karlsson, Paul Karila, Sebastian Illes, Petra Bergström & Henrik Zetterberg. (2020) Partial reduction of amyloid β production by β-secretase inhibitors does not decrease synaptic transmission. Alzheimer's Research & Therapy 12:1.
Crossref
Crossref
Martina Gatti, Manuela Zavatti, Francesca Beretti, Daniela Giuliani, Eleonora Vandini, Alessandra Ottani, Emma Bertucci & Tullia Maraldi. (2020) Oxidative Stress in Alzheimer’s Disease: In Vitro Therapeutic Effect of Amniotic Fluid Stem Cells Extracellular Vesicles. Oxidative Medicine and Cellular Longevity 2020, pages 1-13.
Crossref
Crossref
Ryosuke Arakawa, Akihiro Takano, Per Stenkrona, Vladimir Stepanov, Sangram Nag, Mahabuba Jahan, Per Grybäck, Martin Bolin, Laigao Chen, Lei Zhang, Ping He, Anabella Villalobos, Timothy J. McCarthy, Christer Halldin & Andrea Varrone. (2020) PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [18F]PF-06684511. European Journal of Nuclear Medicine and Molecular Imaging 47:10, pages 2429-2439.
Crossref
Crossref
Allison Bethanne Reiss, Amy D Glass, Thomas Wisniewski, Benjamin Wolozin, Irving H Gomolin, Aaron Pinkhasov, Joshua De Leon & Mark M Stecker. (2023) Alzheimer's Disease: Many Failed Trials, So Where Do We Go from Here?. Journal of Investigative Medicine 68:6, pages 1135-1140.
Crossref
Crossref
Doaa M. Hanafy, Geoffrey E. Burrows, Paul D. Prenzler & Rodney A. Hill. (2020) Potential Role of Phenolic Extracts of Mentha in Managing Oxidative Stress and Alzheimer’s Disease. Antioxidants 9:7, pages 631.
Crossref
Crossref
Doaa M. Hanafy, Paul D. Prenzler, Geoffrey E. Burrows, Saliya Gurusinghe, Bashar M. Thejer, Hassan K. Obied & Rodney A. Hill. (2020) Neuroprotective Activity of Mentha Species on Hydrogen Peroxide-Induced Apoptosis in SH-SY5Y Cells. Nutrients 12:5, pages 1366.
Crossref
Crossref
Christopher D. Morrone, Jossana Bishay & JoAnne McLaurin. (2020) Potential Role of Venular Amyloid in Alzheimer’s Disease Pathogenesis. International Journal of Molecular Sciences 21:6, pages 1985.
Crossref
Crossref
Sarah Bond, Claudia Lopez-Lloreda, Patrick J Gannon, Cagla Akay-Espinoza & Kelly L Jordan-Sciutto. (2020) The Integrated Stress Response and Phosphorylated Eukaryotic Initiation Factor 2α in Neurodegeneration. Journal of Neuropathology & Experimental Neurology 79:2, pages 123-143.
Crossref
Crossref